Matrix Metalloproteinase-7 Associated with Congestive Heart Failure in Peritoneal Dialysis Patients: A Prospective Cohort Study

Background. Matrix metalloproteinase-7 (MMP7) is markedly expressed in patients with chronic kidney disease; its expression in dialysate and role in patients undergoing peritoneal dialysis (PD) have not been well established. Methods. Participants undergoing PD from June 1st, 2015, to June 30th, 202...

Full description

Saved in:
Bibliographic Details
Main Authors: Zhiwen Xiao, Jianwei Tian, Fen Zhang, Xiaohong Zhong, Tingting Zhang, Zhixiu Yi, Yanhong Lin, Cong Yang, Dan Tang, Nirong Gong, Jun Ai
Format: Article
Language:English
Published: Wiley 2023-01-01
Series:Mediators of Inflammation
Online Access:http://dx.doi.org/10.1155/2023/5380764
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849403172038115328
author Zhiwen Xiao
Jianwei Tian
Fen Zhang
Xiaohong Zhong
Tingting Zhang
Zhixiu Yi
Yanhong Lin
Cong Yang
Dan Tang
Nirong Gong
Jun Ai
author_facet Zhiwen Xiao
Jianwei Tian
Fen Zhang
Xiaohong Zhong
Tingting Zhang
Zhixiu Yi
Yanhong Lin
Cong Yang
Dan Tang
Nirong Gong
Jun Ai
author_sort Zhiwen Xiao
collection DOAJ
description Background. Matrix metalloproteinase-7 (MMP7) is markedly expressed in patients with chronic kidney disease; its expression in dialysate and role in patients undergoing peritoneal dialysis (PD) have not been well established. Methods. Participants undergoing PD from June 1st, 2015, to June 30th, 2020, were involved and were followed up every 3 months for the first year and every 6 months thereafter until death, PD withdrawal, or the end of the study. Data at each follow-up point were collected and analyzed for the association with congestive heart failure (CHF), PD withdrawal, and combined endpoint. Results. A total of 283 participants were included in this study. During a median follow-up of 21 months, 20 (7%) participants died, 93 (33%) withdrew from PD, and 105 (37%) developed CHF. A significantly increased level of serum and dialysate MMP7 was observed at baseline. Dialysate MMP7 presented a good linearity with serum MMP7. Baseline serum and dialysate MMP7 levels were associated with CHF in multivariable Cox proportional hazards regression models. After categorization, participants with high baseline MMP7 levels had a higher incidence of CHF (42%), and the hazard ratios (95% confidence intervals) were 1.595 (1.023-2.488). Interestingly, participants with higher serum MMP7 levels were trended to use dialysate with higher glucose concentration. However, the ultrafiltration volumes were not significantly increased. Higher MMP7 levels were also positively associated with PD withdrawal and combined endpoint. Conclusions. The expression of MMP7 in serum and dialysate was markedly increased and was tightly associated with the risk of CHF in PD patients. This finding suggests that the measurement of MMP7 may inform strategies for managing CHF at an earlier stage.
format Article
id doaj-art-934af00cf8a14587853fdfe92c69be01
institution Kabale University
issn 1466-1861
language English
publishDate 2023-01-01
publisher Wiley
record_format Article
series Mediators of Inflammation
spelling doaj-art-934af00cf8a14587853fdfe92c69be012025-08-20T03:37:20ZengWileyMediators of Inflammation1466-18612023-01-01202310.1155/2023/5380764Matrix Metalloproteinase-7 Associated with Congestive Heart Failure in Peritoneal Dialysis Patients: A Prospective Cohort StudyZhiwen Xiao0Jianwei Tian1Fen Zhang2Xiaohong Zhong3Tingting Zhang4Zhixiu Yi5Yanhong Lin6Cong Yang7Dan Tang8Nirong Gong9Jun Ai10State Key Laboratory of Organ Failure ResearchState Key Laboratory of Organ Failure ResearchState Key Laboratory of Organ Failure ResearchState Key Laboratory of Organ Failure ResearchState Key Laboratory of Organ Failure ResearchState Key Laboratory of Organ Failure ResearchState Key Laboratory of Organ Failure ResearchState Key Laboratory of Organ Failure ResearchState Key Laboratory of Organ Failure ResearchState Key Laboratory of Organ Failure ResearchState Key Laboratory of Organ Failure ResearchBackground. Matrix metalloproteinase-7 (MMP7) is markedly expressed in patients with chronic kidney disease; its expression in dialysate and role in patients undergoing peritoneal dialysis (PD) have not been well established. Methods. Participants undergoing PD from June 1st, 2015, to June 30th, 2020, were involved and were followed up every 3 months for the first year and every 6 months thereafter until death, PD withdrawal, or the end of the study. Data at each follow-up point were collected and analyzed for the association with congestive heart failure (CHF), PD withdrawal, and combined endpoint. Results. A total of 283 participants were included in this study. During a median follow-up of 21 months, 20 (7%) participants died, 93 (33%) withdrew from PD, and 105 (37%) developed CHF. A significantly increased level of serum and dialysate MMP7 was observed at baseline. Dialysate MMP7 presented a good linearity with serum MMP7. Baseline serum and dialysate MMP7 levels were associated with CHF in multivariable Cox proportional hazards regression models. After categorization, participants with high baseline MMP7 levels had a higher incidence of CHF (42%), and the hazard ratios (95% confidence intervals) were 1.595 (1.023-2.488). Interestingly, participants with higher serum MMP7 levels were trended to use dialysate with higher glucose concentration. However, the ultrafiltration volumes were not significantly increased. Higher MMP7 levels were also positively associated with PD withdrawal and combined endpoint. Conclusions. The expression of MMP7 in serum and dialysate was markedly increased and was tightly associated with the risk of CHF in PD patients. This finding suggests that the measurement of MMP7 may inform strategies for managing CHF at an earlier stage.http://dx.doi.org/10.1155/2023/5380764
spellingShingle Zhiwen Xiao
Jianwei Tian
Fen Zhang
Xiaohong Zhong
Tingting Zhang
Zhixiu Yi
Yanhong Lin
Cong Yang
Dan Tang
Nirong Gong
Jun Ai
Matrix Metalloproteinase-7 Associated with Congestive Heart Failure in Peritoneal Dialysis Patients: A Prospective Cohort Study
Mediators of Inflammation
title Matrix Metalloproteinase-7 Associated with Congestive Heart Failure in Peritoneal Dialysis Patients: A Prospective Cohort Study
title_full Matrix Metalloproteinase-7 Associated with Congestive Heart Failure in Peritoneal Dialysis Patients: A Prospective Cohort Study
title_fullStr Matrix Metalloproteinase-7 Associated with Congestive Heart Failure in Peritoneal Dialysis Patients: A Prospective Cohort Study
title_full_unstemmed Matrix Metalloproteinase-7 Associated with Congestive Heart Failure in Peritoneal Dialysis Patients: A Prospective Cohort Study
title_short Matrix Metalloproteinase-7 Associated with Congestive Heart Failure in Peritoneal Dialysis Patients: A Prospective Cohort Study
title_sort matrix metalloproteinase 7 associated with congestive heart failure in peritoneal dialysis patients a prospective cohort study
url http://dx.doi.org/10.1155/2023/5380764
work_keys_str_mv AT zhiwenxiao matrixmetalloproteinase7associatedwithcongestiveheartfailureinperitonealdialysispatientsaprospectivecohortstudy
AT jianweitian matrixmetalloproteinase7associatedwithcongestiveheartfailureinperitonealdialysispatientsaprospectivecohortstudy
AT fenzhang matrixmetalloproteinase7associatedwithcongestiveheartfailureinperitonealdialysispatientsaprospectivecohortstudy
AT xiaohongzhong matrixmetalloproteinase7associatedwithcongestiveheartfailureinperitonealdialysispatientsaprospectivecohortstudy
AT tingtingzhang matrixmetalloproteinase7associatedwithcongestiveheartfailureinperitonealdialysispatientsaprospectivecohortstudy
AT zhixiuyi matrixmetalloproteinase7associatedwithcongestiveheartfailureinperitonealdialysispatientsaprospectivecohortstudy
AT yanhonglin matrixmetalloproteinase7associatedwithcongestiveheartfailureinperitonealdialysispatientsaprospectivecohortstudy
AT congyang matrixmetalloproteinase7associatedwithcongestiveheartfailureinperitonealdialysispatientsaprospectivecohortstudy
AT dantang matrixmetalloproteinase7associatedwithcongestiveheartfailureinperitonealdialysispatientsaprospectivecohortstudy
AT nironggong matrixmetalloproteinase7associatedwithcongestiveheartfailureinperitonealdialysispatientsaprospectivecohortstudy
AT junai matrixmetalloproteinase7associatedwithcongestiveheartfailureinperitonealdialysispatientsaprospectivecohortstudy